Interactions between the key regulatory genes of the cardiogenic pathway, including those from the GATA and Nkx2 transcription factor families, are not well defined. Treating neurula-stage Xenopus embryos with retinoic acid (RA) causes a specific block in cardiomyocyte development that correlates with a progressive reduction in the region of the presumptive heart-forming region expressing Nkx2.5. In contrast, RA does not block expression of the GATA-4/5/6 genes, which are transcribed normally in an overlapping pattern with Nkx2.5 throughout cardiogenesis. Instead, GATA-4/5/6 transcription levels are increased, including an expansion of the expression domain corresponding to lateral plate mesoderm that is part of the early heart field, but that normally is progressively restricted in its ability to contribute to the myocardium. GATA-dependent regulatory sequences of the Nkx2.5 gene that implicate GATA-4/5/6 as upstream positive regulators were described recently. However, our experiments also indicate that GATA factors might normally antagonize transcription of Nkx2.5. To test this hypothesis we generated a dominant negative isoform of GATA-4 (SRG4) capable of inhibiting transcription of GATA-dependent target genes. Ectopic expression of SRG4 results in a transient expansion of the Nkx2.5 transcript pattern, indicating that a normal function of GATA factors is to limit the boundary of the Nkx2.5 expression domain to the most anterior ventral region of the heart field. Regulatory mechanisms altered by excess RA must function normally to limit GATA-4/5/6 expression levels, to define the region of Nkx2.5 expression and regulate myocardial differentiation.
INTRODUCTION
The vertebrate heart develops from bilateral heartforming regions of lateral plate mesoderm, believed to be specified before or during gastrulation (for review, see Lyons, 1996; Mohun and Sparrow, 1997) . Experiments in Xenopus determined that signals from the organizer (Sater and Jacobson, 1990b) and deep endoderm (Nascone and Mercola, 1995) induce lateral mesoderm adjacent to Spemann's organizer to become heart. The exact nature of this inductive signaling event is not known, although bone morphogenetic proteins appear to play a significant role in initiating the cardiogenic program (Schultheiss et al., 1997) . Genes from two transcription factor families are expressed during early development in overlapping patterns within mesoderm and associated anterior endoderm of the presumptive heart-forming region. One set of factors includes GATA-4/5/6 of the GATA family of zinc finger-containing transcription factors (Jiang and Evans, 1996; Kelley et al., 1993; Laverriere et al., 1994) and the other is the Nkx2 (Csx) family of homeoboxcontaining transcription factors (Evans et al., 1995; Newman and Krieg, 1998; Tanaka et al., 1998; Tonissen et al., 1994) related to the Drosophila heart-specification gene called tinman (Bodmer, 1993) .
The early coexpression of Nkx2 and GATA factors in the cardiac crescent, prior to expression of known cardiomyocyte differentiation genes, is consistent with a model in which members of both families cooperate in specifying or otherwise regulating the development of cardiogenic progenitors (Charron and Nemer, 1999; Evans, 1997) . Both subfamilies are implicated in regulating the expression of multiple cardiac-specific genes (Grepin et al., 1994; Ip et al., 1994; Lyons et al., 1995; Molkentin et al., 1994) and may do so by physical interaction within a common protein complex (Durocher et al., 1997; Durocher and Nemer, 1998; Sepulveda et al., 1998) . The importance of Nkx2 and GATA factors in heart development has been tested by loss-offunction experiments. Expression of dominant-interfering isoforms of Nkx2 proteins results in a complete block to Xenopus heart development (Fu et al., 1998; Grow and Krieg, 1998) . However, gene disruption experiments in mice have not demonstrated cell-specification functions for individual Nkx2 or GATA family members, but are instead consistent with critical roles in heart tube morphogenesis. For example, disruption of Nkx2.5 leads to a nonlooping heart tube phenotype (Lyons et al., 1995; Tanaka et al., 1999) , and mutations in the human gene are identified as causing congenital heart disease (Schott et al., 1998) . In the GATA-4 null mutant mouse there is a failure of the two heart primordia to fuse at the ventral midline, although cardiac differentiation in the twinned bifid hearts that develop appears normal (Kuo et al., 1997; Molkentin et al., 1997) . The primary abnormality of these mice is likely to be defective endoderm development, leading by an unknown mechanism to failure in fusion of the two heart primordia (Narita et al., 1997) . Some less obvious aspects of cardiomyocyte differentiation may also be affected by the Nkx2.5 and GATA-4 mutations, and additional roles in cardiomyocyte specification may be compensated by other family members.
In comparison to the Nkx2 family, for which there is evidence of function in cardiomyocyte development (Cleaver et al., 1996) , the genetic role for GATA factors during cardiogenesis appears relatively complex. has been demonstrated to have a positive effect on the expression of cardiac differentiation genes (Grepin et al., 1997) , so that it would appear that different GATA factors can have some nonoverlapping functions. Overexpression of GATA-6 in Xenopus embryos was observed to block the differentiation of heart precursors (Gove et al., 1997) , suggesting that a decline in GATA-6 expression levels may be a cue for cardiomyocyte differentiation. In mice, GATA-6 is required for extraembryonic development and thus mice lacking this gene die before a potential role in cardiac differentiation can be assessed (Koutsourakis et al., 1999; Morrisey et al., 1998) , although GATA-6 mutant ES cells are able to contribute to the heart in chimeric embryos. However, using antisense oligonucleotides, it is necessary to deplete transcripts encoding each of the three chick genes to detect cardiac abnormalities, indicating that all three GATA factors act in a common morphogenetic pathway . Therefore, GATA factors may be important for endoderm and mesoderm development related to cardiomyocyte proliferation and differentiation, as well as heart tube formation and morphogenesis.
Retinoids regulate an important signaling pathway for cardiogenesis, and either an excess or a deficit of retinoic acid (RA) is disruptive to normal heart development. Similar cardiogenic defects are caused by a lack of embryonic retinoids (Zile, 1998) or if retinoid signaling is blocked through targeted disruption of retinoid receptor genes (Gruber et al., 1996; Kastner et al., 1994; Lee et al., 1997; Luo et al., 1996; Sucov et al., 1994) . Retinoids may also be important for the diversification of atrial and ventricular tissues and in the regulation of chamber-specific gene expression (Yutzey et al., 1994 (Yutzey et al., , 1995 . The GATA-4 gene fails to be expressed in vitamin A deficient (VAD) quail embryos that develop an abnormal nonlooping heart tube, while Nkx2.5 expression levels are not grossly affected (Kostetskii et al., 1999) . These experiments link a requirement for retinoids in establishment of a specific GATA-dependent cardiac transcriptional program associated with posterior heart tube development and tube morphogenesis. In Xenopus, addition of RA blocks cardiac differentiation, even if applied after expression patterns for Nkx2 and GATA factors are established (Drysdale et al., 1997) . Transcript levels for Nkx2.5, Nkx2.3 (Drysdale et al., 1997) , and Nkx2.9 (P. A. Krieg, personal communication) decline rapidly in the heart-forming region in response to RA exposure. The decline in transcripts encoding tinman-related genes may be responsible for the block to cardiac differentiation. Alternatively, retinoic acid may be acting upstream of the Nkx2 genes on a more general cardiac development program. In this system RA is unlikely to be affecting cell specification because Xenopus heart specification is completed by the end of gastrulation (Sater and Jacobson, 1989) , while RA can affect heart differentiation of mid-neurulastage embryos.
Because the expression patterns of the Nkx2 and GATA factors are largely overlapping during early cardiogenesis, it is feasible that they might regulate the expression of each other; indeed the mouse promoter for Nkx2.5 has binding sites for GATA factors and itself (Lien et al., 1999; Searcy et al., 1998) . There is evidence from the analysis of mouse mutations that cross-talk can occur between the GATA-4 and the GATA-6 genes; meanwhile, Nkx2.5 is not required for normal expression of GATA-4 (Tanaka et al., 1999) . In the Xenopus model, using retinoic acid to block expression of Nkx2 expression and heart development allows us to test if GATA factors are dependent on Nkx2 expression or are coregulated by a common or linked signaling pathway. We find that GATA factors are not dependent on Nkx2.5 for expression, nor are GATAs sufficient for expression of Nkx2.5 or for cardiac differentiation. Ectopic expression of a dominant negative GATA-4 confirms that GATA factors may normally restrict the expression domain of Nkx2.5 and that down-regulation of GATAs during neurula stages might be an important component of the normal cardiogenic program.
MATERIALS AND METHODS

Embryo and Explant Culture
Mature Xenopus females were injected with 700 -800 IU of human chorionic gonadotrophin (Sigma) and the ovulated eggs were fertilized in vitro using minced testis. Embryos were dejellied with 2.5% cysteine, pH 8.0, and cultured in 20% Steinberg's solution or 0.1ϫ MBS. Embryos were staged according to Nieuwkoop and Faber (1967) . Explants were isolated using fine forceps and cultured in modified Danilchik's medium (Peng, 1991) without BSA. Culture dishes were coated with a thin layer of 1% agarose.
Retinoic Acid Treatment
Retinoic acid (all-trans; Sigma) was prepared as a 1 mM stock solution in dimethyl sulfoxide (DMSO). Embryos were immersed in 1 M retinoic acid at various embryonic stages and unless stated the treatment was continuous. Control embryos were treated with 1 l/ml DMSO.
RNA Analysis
Whole-mount in situ hybridization was performed as described (Jiang and Evans, 1996) . The Xenopus GATA-4/5/6 cDNA clones used to generate the probes are also described (Jiang and Evans, 1996) and the xNkx2.5 probe is described in Tonissen et al. (1994) . The TnIc probe was prepared as described . The xSox17␣ probe was a gift from the H. R. Woodland lab (Hudson et al., 1997) and prepared following SmaI digestion using T7 polymerase. In some experiments, embryos were postfixed, washed in water, dehydrated, washed twice in xylenes, and then infused with paraplast overnight. After embedding, paraplast blocks were trimmed and 10-sections cut and floated onto "Superfrost Plus" microscope slides (Fisher), dried overnight, dewaxed in xylenes, and coverslipped using Permount (Fisher). Semiquantitative RT/PCR to measure transcript levels of GATA-4 and EF-1␣ was performed as described (Jiang and Evans, 1996) and quantified by phoshorimaging following gel electrophoresis.
Dominant Negative xGATA-4 (SRG4)
A region of the xGATA-4 cDNA encompassing both zinc fingers and the entire DNA-binding domain (from amino acid 147 to 304) was isolated by PCR using primers that incorporated a stop codon and permitted in-frame fusion at the N-terminus with sequences encoding the strong repression domain (amino acids 1-69) of the mouse Mxi1 gene (Schreiber-Agus et al., 1995) . The Mxi1 cDNA was a gift from the R. DePinho laboratory. The chimeric cDNA encoding a protein called SRG4 was confirmed by sequencing and then subcloned into vector pCDNA3, for both in vitro transcription/translation and transfection experiments in tissue-culture cells, and into vector pGEMHE (providing globin gene untranslated sequences) for in vitro transcription to generate capped RNA for microinjection. For control experiments, a near-identical cDNA was generated (mtSRG4) containing a single mutation of the SR domain (Mxi-SR-pro; a proline for leucine substitution at amino acid residue 19 (Schreiber-Agus et al., 1995) ) that abolishes the ability of SR to interact with sin3 or repress transcription. The SRG4 protein was tested for activity using in vitro-generated rabbit reticulocyte lysates (Promega) by gel mobility-shift experiments as described (Yang and Evans, 1992) . Cotransfection experiments into QT6 fibroblasts were performed and analyzed as described (Evans and Felsenfeld, 1991; Gao et al., 1998) , using the GATA-4, SRG4, and mtSRG4 expression plasmids and the ␣D3-luc and pCH110 ␤-galactosidase reporter plasmids. The ␣D3-luc reporter is identical to that described (Evans and Felsenfeld, 1991) except that the CAT gene is replaced with a luciferase coding sequence derived from pGL3basic (Promega). Each transfection contained 2 g reporter, a total of 4 g of expression vectors, and 0.25 g internal control reporter. For microinjection experiments, capped mRNA was prepared in vitro from linearized pGEMHE/ SRG4 using a kit from Ambion. To determine the left/right embryonic axis, fertilized eggs were tipped in medium containing 7% Ficoll and marked on the presumptive dorsal side using Nile blue dye as described (Peng, 1991) . At the eight-cell stage, a single left dorsal/vegetal blastomere was injected with 4.5 nl of solution containing 250 pg SRG4 RNA (or in control samples, mtSRG4 RNA) in water containing 5 mg/ml fluorescein-dextran (Molecular Probes; D-1820), to facilitate lineage tracing.
RESULTS
GATA-4/5/6 Transcription Is Not Inhibited in RATreated Embryos That Fail to Express Cardiomyocyte Markers
It was shown previously that treatment of Xenopus embryos with 1 M RA at stage 20 blocks differentiation of the heart and causes a rapid loss of Nkx2.5 and Nkx2.3 transcripts in the presumptive heart region. In contrast to myocardial markers, endocardial development is apparently resistant to this treatment, indicated by persistent expression of the X-msr gene (Drysdale et al., 1997) . A superficially normal heart tube forms that fails to loop or form any beating tissue. The loss of expression in the tinman-related genes might be sufficient to explain the subsequent failure to express markers of myocardial differentiation at later stages, or it might reflect a more general loss of the cardiovascular gene expression program. In the latter case, a loss of GATA-4/5/6 expression in the RA-treated embryos might be predicted, given the overlapping expression patterns of these two gene families throughout early cardiovascular development.
As shown in Fig. 1a , treatment of embryos at stage 20 with 1 M RA results in a near-complete loss of Nkx2.5 and cardiac troponin I (TnIc) transcripts. The loss is complete in many embryos, but the examples shown here indicate the position of the presumptive heart and illustrate an important point. Treatment of embryos with RA does not diminish equally transcript levels throughout the heart-forming region. Rather, the spatial domain of transcripts is progressively deleted toward the ventral midline, so that in many cases only a small region of ventral tissue expresses Nkx2.5 and a myocardial differentiation program. Note that Nkx2.5 transcripts are detected readily in pharyngeal endoderm, an anterior tissue that is not a normal expression domain for GATA factors. In surprising contrast, we find that all three GATA family members are expressed in the RAtreated embryos and the domains of expression are even somewhat expanded. The patterns, as detected by wholemount in situ hybridization, are similar but not identical for each of the three genes. In RA-treated embryos, the patterns extend more broadly dorsal and caudal relative to control embryos. The expanded domain that encompasses the GATA-4/5/6 pattern does not correspond in any obvious manner to a specific tissue. For both GATA-5 and GATA-6, there was in addition ectopic expression of transcripts detected around the developing hindgut (Fig. 1b) .
FIG. 1.
GATA-4/5/6 transcription is not inhibited by RA treatment, which blocks myocardial differentiation. (a) Whole-mount in situ hybridization was performed using probes specific to transcripts for cardiac troponin I, Nkx2.5, or GATA-4/5/6, as indicated on the right. Embryos are oriented with anterior to the left, dorsal to the top. RA was added at stage 23 and embryos were allowed to develop until stage 35. Examples of control embryos, treated with DMSO alone, are shown on the left; examples of RA-treated embryos are on the right. The arrow and arrowheads in the two upper right images indicate the small patch of differentiated myocardium that remains in these embryos, at the most ventral position of the presumptive heart-forming region. Note that the pharyngeal endoderm, which does not express GATA-4/5/6, remains positive for Nkx2.5 following RA treatment. The Nkx2.5 levels appear increased in pharyngeal endoderm of this RA-treated embryo due to extended staining in order to observe the weak signal in the residual heart region. However, enhanced levels of Nkx2.5 RNA are not observed generally in pharyngeal endoderm of RA-treated embryos (Drysdale et al., 1997) . (b) An example of an RA-treated embryo analyzed for xGATA-6 RNA to illustrate the induction of a posterior domain of transcription (arrow). A similar activation is seen for GATA-5 but not for GATA-4. Our previous work implicated GATA-6 in the regulation of progenitor cells of the gut (Gao et al., 1998) , and so this domain is likely to correspond to the presumptive hindgut.
RA-Treated Embryos Maintain both Mesodermal and Endodermal Expression of GATA Factors
GATA-4/5/6 are expressed normally in both the precardiac mesoderm and the associated endoderm of the presumptive anterior foregut. Therefore, the expression of GATA factors in RA-treated embryos might reflect a relative expansion of the endodermal expression domain relative to the presumptive myocardium. To characterize further the transcript patterns for xGATA-4/5/6, RA-treated and control embryos were sectioned following wholemount in situ hybridization. As shown in Fig. 2a (sagittal sections), transcripts of xGATA-4/5/6 persist in the unfolded layer of tissue that would normally have formed differentiated myocardium and the endocardium of the RA-treated embryos. Expression in the persisting endocardial layer as well as the closely associated anterior endoderm is more easily analyzed in cross section, as shown for example with GATA-4 in Fig. 2b . Similar patterns were found for GATA-5 and GATA-6 (not shown).
Early Exposure to RA Further Enhances GATA-4 Expression in the Complete Absence of Anterior Structures
When retinoic acid is applied to Xenopus embryos at the end of neurulation, it affects specifically the developing heart region while the rest of the embryo is relatively normal. Although there is no detectable myocardialspecific gene expression, there is limited cardiac morphogenesis (Drysdale et al., 1997) . When retinoic acid is applied prior to gastrulation, there is a general loss of all anterior structures including heart (Durston et al., 1989; Sive et al., 1990) . This complicates interpreting a direct relationship between the addition of retinoic acid at early stages and cardiac development, but does allow us to determine whether the persistent expression of GATA factors is dependent on the initial presence of a cardiogenic program.
We examined embryos exposed continuously to 1 M RA starting at gastrulation (stage 10.5) or at midneurula (stage 14/15) and compared development and expression patterns with control embryos and those treated at stage 20. In embryos treated early we obtained the expected axis defects and general loss of anterior structures. In those embryos, the expression of GATA-4/5/6 genes, particularly GATA-4, is not only detected at the anterior ventral region, but also expanded to the dorsoanterior boundary (Fig. 3a) , while Nkx2.5 transcripts are not detected. Examination of sections from the embryos reveal that the GATA transcripts are present in the presumptive mesoderm and the associated endoderm cells, similar to the pattern in control embryos but enhanced. This is particularly obvious in the case of GATA-4, as shown in Fig. 3b . We used a probe to the endoderm marker Sox17␣ (Hudson et al., 1997) to demonstrate that endoderm and mesoderm are both still present in the RA-treated embryos and that GATA-4 transcripts persist clearly in the mesoderm layer (Fig. 3b) . To further confirm that RA treatment results in an increase in the transcript levels of GATA-4, embryos were exposed to continuous RA treatment from stage 10.5, either for 4 h or to stage 30; RNA was isolated and assayed for GATA-4 transcripts by semiquantitative RT/PCR. In either case, the levels of GATA-4 transcripts are increased twofold in the RA-treated embryos relative to the control embryos (Fig.  3c) .
A Dominant Negative Form of xGATA-4 Can Inhibit the Activation of GATA Target Genes
Our observation that expression levels of xGATA-4/5/6 genes are increased by RA treatment while the Nkx2.5 gene is coordinately inactivated leads to the unexpected possi- bility that GATA genes and the Nkx2.5 gene might have some functions in cardiogenesis that are antagonistic. To further investigate the genetic relationship between GATA genes and Nkx2.5, a dominant negative form of GATA-4 was generated (SRG4, Fig. 4a ) by fusing the "strong repression" (SR) domain of the murine Mxi1 protein to the amino-terminus of a peptide encompassing the DNAbinding domain from GATA-4 (G4). The SR domain of Mxi1 interacts with the general chromatin repressor protein sin3 to mediate suppression of myc oncogenic activity (Schreiber-Agus et al., 1995) . It has been shown that when fused to a heterologous DNA-binding domain, the SR domain can target sin3 to gene-specific binding sites leading to repression (Harper et al., 1996) . A mutant form of SRG4 (mtSRG4) was also generated, containing a single amino acid alteration of the SR domain that abolishes interaction with sin3 and is unable to repress transcription.
The SRG4 (and the mtSRG4; not shown) bind specifically to a consensus GATA-binding cis-element (Fig. 4b) . The ability of the SRG4 construct to suppress transcription directed by GATA-4/5/6 was tested in a cell culture system. In this study, each of the three cardiac GATAs transactivates a model GATA-dependent reporter gene approximately eightfold (an example is shown for GATA-4 in Fig.  4c ). Coexpression of SRG4 in the transfection assay completely suppresses the trans-activation, even below the basal level. In the experiment shown, the SRG4 expression vector is in threefold excess over the GATA-4 expression vector, but suppression to basal level is found even using equal ratios (not shown). Coexpressed SRG4 was equally capable of suppressing activation of the reporter by GATA-5 and GATA-6 (not shown). In contrast, the control mtSRG4 was unable to inhibit activation by wild-type GATA-4 (Fig.  4c) . Similar results were found for a protein consisting of the DNA-binding domain of GATA-4 alone; if expressed in further excess this protein or the mtSRG4 protein could inhibit coexpressed wild-type GATA-4 activity only about twofold (not shown). Therefore, SRG4 can function as a dominant negative isoform by competing with wild-type GATA factors to inhibit activation of GATA-dependent targets.
Expression of SRG4 Expands the Posterior Expression Domain of the Nkx2.5 Gene during Early Stages of Cardiogenesis
Our data using exogenous RA treatment correlated increased expression of GATA factors with inhibition of Nkx2.5. If this represents a genetic interaction, a prediction can be made that decreasing GATA factor activity might result in enhanced expression of Nkx2.5. To inhibit GATAdependent gene expression in vivo, in vitro-transcribed SRG4 mRNA was injected into a left dorsal-vegetal blastomere of eight-cell-stage embryos. According to the fate map (Moody, 1987) , the dorsal-vegetal blastomeres contribute to the future heart. In control experiments, RNA encoding mtSRG4 was injected. The injected embryos were assayed by whole-mount in situ hybridization at stage 26/27 for the transcription of Nkx2.5, just prior to fusion of the two bilateral primordia at the ventral midline. As shown in Fig. 5a , the Nkx2.5 transcript pattern is seen in control (lacZ injected) embryos in symmetric patches of presumptive heart myocardium, as well as pharyngeal endoderm. In 42% of the embryos injected with SRG4 RNA, an asymmetric Nkx2.5 transcription pattern was detected (64/152, compared to 2% of the mtSRG4-injected embryos; see Table 1 ). This expanded domain of expression was not seen when embryos were injected with other RNAs, including those encoding full-length GATA-4. Of the embryos with asymmetric expression (estimated visually as having one side roughly twice or more the area of the other), the expanded pattern was detected in 80% of the cases on the presumed injected (left) side. Analysis of co-injected lineage tracer confirmed that the accuracy of targeting RNA to the left dorsal-vegetal blastomere was 75%. The expanded domain of Nkx2.5 transcripts is restricted to mesoderm and is located primarily in a domain more posterior to that found in normal embryos (Fig. 5b) .
The embryos injected with either SRG4 or mtSRG4 generally went on to develop without obvious abnormalities. The expression of SRG4 is for technical reasons transient and is presumably overcome by normal expression of GATA factors in the developing cardiovascular region. It is not surprising that the hearts of SRG4 embryos are normal, given the regulative ability of Xenopus embryos to control heart size. We attempted to increase the amount of SRG4 by targeting both sides of the developing heart. Unfortunately, injection into both dorsal/vegetal blastomeres at the eight-cell stage results in severe phenotypic abnormalities in a high percentage of embryos that complicated further analysis of cardiogenesis (short, stubby embryos displaying an expanded "pigeon chest," but with no consistent heart phenotype). We conclude that inhibition of GATAdependent gene expression leads to ectopic Nkx2.5 transcription, consistent with a normal function for GATA factors in regulating the Nkx2.5 expression domain.
DISCUSSION
GATA-4/5/6 Expression Is Enhanced in Response to Retinoic Acid, Concurrent with Decreased Transcription of Nkx2.5 and a Failure in Cardiomyocyte Differentiation
The phenotype of the neurula-stage RA-treated embryo is a strikingly specific defect in Nkx2 gene expression and a block to myocardial differentiation. Given the overlapping coexpression of GATA and Nkx2 family members throughout early stages of heart development, it might be predicted that these embryos would have a similar defect in GATA factor expression. However, transcription of GATA-family members is activated, rather than inhibited, by retinoid signaling (Arceci et al., 1993; Boylan et al., 1995; Kostetskii FIG. 5 . Ectopic targeted expression of SRG4 results in an expanded pattern of Nkx2.5 transcription. Examples are shown of embryos injected at the 8-cell stage into one left-side dorsal-vegetal blastomere with RNA encoding control LacZ RNA, mtSRG4, or SRG4, as indicated. Embryos were fixed at stage 26 and analyzed by whole-mount in situ hybridization for Nkx2.5 transcripts; processed embryos are viewed from the ventral side, anterior is up. The control embryo is slightly older so the right (R) and left (L) sides of the primitive heart tube are fusing at the midline. Compared to the symmetric pattern seen here or in the prefusing primordia of the mtSRG4-injected embryo, the SRG4-injected embryos display an expanded domain of Nkx2.5 transcription in the left primordium (arrows). (b) An embryo injected in the left blastomere with SRG4 RNA was processed as in (a), and sections were taken through the region of the fusing primordia. Shown are four sections taken from progressively more posterior regions (left to right). Note that in the most anterior regions the Nkx2.5 pattern is not significantly changed, but left-side enhanced transcripts are detected in more posterior sections (arrows).
FIG. 4. SRG4 functions as a dominant negative isoform capable of inhibiting activation of GATA-4 targets. (a)
Schematic illustration of the domain structure of SRG4. The strong repression (SR) domain of Mxi.1 is fused to a region of GATA-4, containing both zinc fingers (cc cc), that constitutes the DNA-binding and cofactor interaction domains of GATA-4. A control isoform (mtSRG4) was also generated, containing a single amino acid change (leucine to proline, p) that abolishes the ability of SR to repress gene expression. SRG4 is predicted to repress GATA-dependent target genes through interaction with normal GATA-binding sites containing a WGATAR consensus sequence. (b) A gel mobility-shift experiment demonstrates that SRG4 binds with specificity to a consensus GATA cis-element. The GATA-binding probe (P) was end-labeled and incubated with rabbit reticulocyte lysate charged with in vitro-generated RNA encoding SRG4. The reaction included no competitor (0) or a 50-fold molar excess of unlabeled oligomer containing the same specific (sp) binding site or a similar oligomer containing a mutation (mt) of the GATA motif. (c) A well-characterized GATA-dependent reporter (␣D3-luc) was cotransfected into QT6 fibroblasts with (ϩ) or without (0) a GATA-4 expression vector, along with an empty vector (to maintain total amount of vector DNA), mtSRG4, or SRG4 as indicated. The level of activation relative to the basal promoter activity is shown after normalizing for activity of a cotransfected ␤-galactosidase reporter that is not regulated by GATA-4 expression. The results shown are from three independent experiments, each performed in duplicate; red stacked bars represent standard deviation. SRG4 was equally capable of repressing activation by xGATA-5 or xGATA-6 (not shown).
et Soudais et al., 1995) . Regulation of retinoid signaling is a conserved component of normal cardiogenesis and excess RA present during pregnancy or administered directly to embryos or precardiac fields causes severe cardiac abnormalities, including cardia bifida (Hoffman and Eichele, 1994; Smith and Dickman, 1997) . Although many studies have documented changes in cardiomyocyte development in the presence of excess retinoids, these results must be interpreted with caution because it is not yet established that the phenotypes are related mechanistically to normal development. In our studies regarding the influence of exogenous RA on the regulation of Nkx2.5 and GATA factors, we feel that the results are likely to be of relevance for several reasons:
First, the phenotype is specific to the developing heart in embryos that appear otherwise quite normal, so the effect is unlikely to be derived from an indirect teratogenic response, for example, as seen when early treated embryos show a general loss of anterior structures, including the heart. The phenotype is seen when embryos are treated at the neurula stage, long after specification and axis patterning is thought to be finished. Second, the phenotype is consistent (and opposite) to that seen in mice with targeted disruptions in retinoic acid receptor genes (Kastner et al., 1997) . These mutant mice display defective cardiac morphogenesis with a thin myocardium attributed to precocious ventricular cardiomyocyte differentiation. Therefore, a lack of retinoid signaling accelerates differentiation, while in our studies excess retinoids block differentiation. Finally, and most importantly, the expression patterns for GATA-4 and Nkx2.5 following RA treatment are exactly what would be predicted based on our analysis of the vitamin A-deficient quail embryo, completely lacking in embryonic retinoid signaling. This embryo, which has a differentiated myocardium but a severe heart tube morphogenetic defect, fails to express GATA-4, while Nkx2.5 transcripts are still present. Therefore, in the absence of RA the GATA-4 gene is off and the Nkx2.5 is on, while in the presence of excess RA the GATA-4 transcript pattern is enhanced and the Nkx2.5 gene is turned off. Retinoic-responsive elements in the Nkx2.5 gene are not described. Our data implicate GATA factors as an intermediary and are consistent with a normal function for RA in regulating the embryonic expression pattern of GATA factors with relevance to the developing cardiovascular system.
GATA Factors May Function Upstream of Nkx2, but Are Not Sufficient in the Absence of Nkx2 Expression to Direct Cardiomyocyte Development
Transcripts for GATA-4/5/6 can be detected faintly as early as stage 3 in gastrulating cells of the chick primitive streak that include the cardiogenic progenitors. Although it is not known if functional protein is expressed this early, by the cardiac crescent stage transcripts for all three genes are detected readily in largely overlapping patterns throughout a broad region of lateral plate mesoderm and associated endoderm, in cells that eventually generate (among other things) endocardium, myocardium, great vessel endothelia, and foregut endoderm. This early pattern of GATA factor expression therefore marks cells that contribute generally to the cardiovascular system, while part of the Nkx2.5 pattern is overlapping, within those progenitors that will form the myocardium. Our results suggest that the observed changes in GATA expression may play a role in the loss of Nkx2.5 expression in the presumptive heart region. As the exogenous RA is able to block the differentiation of the heart, it would suggest that GATA factors alone are unable to allow cardiac differentiation and thus implicate Nkx2 family members as playing an essential role in this process. There is no direct evidence from mouse mutational studies that GATA factors regulate Nkx2 family members or vice versa. However, these analyses are complicated by likely functional redundancy among family members. Indirect evidence that GATA factors function upstream of and regulate the expression of Nkx2.5 comes from transgenic mouse experiments that determined functionally relevant enhancer sequences of the Nkx2.5 gene that contain GATA binding sites (Lien et al., 1999; Searcy et al., 1998) . These experiments indicate that activation of the Nkx2.5 gene in presumptive cardiomyocytes is dependent on GATA factors. If this were a direct epistatic relationship we would predict that expression of a dominant negative GATA-4 isoform might reduce Nkx2.5 transcript levels. Instead the opposite result was obtained; the pattern of Nkx2.5 was expanded in a significant fraction of the embryos, particularly along the ventral/caudal midline, in cells that do not normally contribute to the myocardium. Note. Embryos were injected at the 8-cell stage in a single left dorsal-vegetal blastomere with 250 pg of RNA encoding either SRG4 or mtSRG4. Embryos were fixed at stage 26 and analyzed for Nkx2.5 transcripts as shown in Fig. 5 . Left Ͼ right indicates embryos with an expanded domain of Nkx2.5 on the left heart primodium, prior to fusion; 2 such embryos are shown for example in Fig. 5a . To determine the accuracy of targeting, 244 embryos were analyzed by fluorescence microscopy before being fixed for the co-injected dextran tracer. In this case, 183 (75%) were FITCpositive primarily on the left side. The other embryos were injected mistakenly on the right side, or the analysis was complicated by cell mixing. The lineage tracing results indicate that the 13 SRG4-injected embryos showing a right Ͼ left pattern can be explained by mistargeting of the injected RNA.
Although this result may appear counterintuitive, it is entirely consistent with the expression of Nkx2.5 when GATA factor activity is affected by alterations in retinoid signaling. Therefore, increased expression of GATA factors in the RA-treated Xenopus embryos correlates with decreased transcription of Nkx2.5. Similarly, depletion of GATA factors in the VAD embryo does not lead to a lack of Nkx2.5. The transcript levels for Nkx2.5 in the VAD quail were not quantified, but we predict that they might even be enhanced in the GATA-4-deregulated embryos. In this case an argument for functional compensation of Nkx2.5 expression by GATA-6 is unlikely, because GATA-6 transcripts are also decreased in the VAD embryo, albeit less dramatically relative to GATA-4. A simple hypothesis that is consistent with our data in RA-treated frog embryos, the VAD quail embryo, the SRG4-injected frog embryos, and the transgenic mouse experiments is that GATA factors regulate the expression of Nkx2.5 but can do so in either a positive or a negative manner, depending on the cell context. Therefore, in presumptive cardiomyocytes, GATA factors might activate or maintain the expression of Nkx2.5, while in regions of the embryo posterior and lateral to the myocardial progenitors (for example, in the region of the developing inflow tract) GATA factors might inhibit the Nkx2.5 gene. This differential regulation by GATA factors could be important either in defining the myocardial subpopulation or in patterning of the developing heart tube along the anterior/posterior axis. Currently, the mechanism for differential regulation of Nkx2.5 can only be speculated, but could involve cell-or region-specific cofactors different levels of specific GATA factors, or posttranslational modification of specific GATA factors. Perhaps most interesting, the GATA cofactor FOG-2 mediates either activation or repression of GATAdependent promoters, depending on the gene and the cell type tested (Lu et al., 1999; Svensson et al., 1999) . This is precisely the type of mechanism that could lead to differential regulation of Nkx2.5 by GATA factors in the developing heart.
A Potential Role for GATA Factors in Regulating the Boundaries of the Precardiac Field
The concept of a heart morphogenetic field refers to that region of the embryo that is capable of contributing to the developing heart, including progenitors that do not normally do so. The presence and boundary of a field can be determined experimentally in explant assays (that presumably relieve some cells of the field from negative regulatory mechanisms that normally restrict cardiac differentiation) or in cell-ablation experiments (in which additional cells of the field are redirected to a heart cell fate by unknown regulatory mechanisms to compensate for those that are lost). For example, explant assays that scored for the presence of beating heart tissue showed that in Xenopus neurula embryos (stage 20) the area that can form heart tissue includes anterior ventral and ventrolateral mesoderm (Sater and Jacobson, 1990a) . By stage 28 the field is restricted to the anterior ventral mesoderm. The molecular basis of how a heart field is restricted has until recently been elusive. However, we note that the expanded domain of GATA factor expression seen in stage 20 RA-treated embryos corresponds at least in part to the lateral mesoderm that is initially part of the heart field but normally loses potency. GATA factors may therefore represent molecular markers for the initial heart field, which becomes blocked from further development in the RA-treated embryos. Indeed, recent cell-ablation experiments in zebrafish support the hypothesis that GATA-4 expression delineates the boundary of the heart field. In zebrafish, only the anterior half of the Nkx2.5-positive lateral plate mesoderm contributes to the cardiogenic progenitor population. When cells of the normal cardiogenic region are ablated, more anterior cells that express GATA-4 acquire a cardiac cell fate (Serbedzija et al., 1998) .
Our data support a model in which the pattern of GATA factor expression helps determine the boundary of the cardiac field and the levels are critical to regulating the normal progression to a differentiated heart. GATA factors might be required for the activation or maintenance of an Nkx2-dependent cardiac differentiation program, but the levels and boundaries must also be controlled to allow restriction of the heart field and permit terminal differentiation. Therefore (see Fig. 6 ), overexpression of GATA-6 leads to a reduction in the potential of cells to express a differentiated cardiomyocyte program (Gove et al., 1997) . According to this model (Fig. 6,  middle) , it might be predicted that overexpression of wild-type GATA-4 would lead to a reduction in the expression domain of Nkx2.5. However, we did not find this, nor were changes in the Nkx2.5 transcript patterns detected by GATA-6 overexpression in the study by Gove et al. (1997) . Therefore, GATA factors themselves may not be limiting in the control of Nkx2.5 and probably do not function alone in this capacity, but downstream of and/or in parallel to other genes regulated by RA. In contrast, repression of GATA-dependent target genes (using the dominant negative isoform SRG4) leads to an expansion of the Nkx2.5 transcript pattern, indicating that one or more GATA target genes function normally in defining the Nkx2.5 pattern and restricting those cells of the cardiac field that are competent for myocardial development. The dominant negative isoform may interfere with pathways for each of the GATA-4/5/6 factors, resulting in a transient depletion of some factor(s) needed for proper heart patterning. Depletion of any single GATA factor might not be sufficient to generate a similar result. We note that aspects of this mechanism may be relevant only in vertebrate species that have a regulative heart field (Ehrman and Yutzey, 1999) .
GATA Factors Have Multiple Functions in Cardiovascular Development
From this work we conclude that expression of GATA factors in precardiac mesoderm is not sufficient to activate a myocardial differentiation program. Instead, the data indicate that GATA factor activity may need to be moderated for differentiation to proceed, consistent with the misexpression experiments using GATA-6 (Gove et al., 1997) and providing indirect evidence that GATA factors in heart mesoderm define the boundaries of the cardiac morphogenetic field. This adds to a growing list of experimentally determined functions for GATA factors in the developing cardiovascular system, including development of cardiac-associated endoderm (Narita et al., 1997 , and our unpublished results), heart tube formation and morphogenesis Kostetskii et al., 1999; Kuo et al., 1997; Molkentin et al., 1997) , cardiomyocyte proliferation (Gove et al., 1997) , cardiomyocyte differentiation (Grepin et al., 1995 (Grepin et al., , 1997 , hypertrophic response (Molkentin et al., 1998) , and great vessel smooth muscle cell differentiation (Mano et al., 1999; Suzuki et al., 1996) . In contrast to GATA factors in the hematopoietic system, which appear to control primarily cell proliferation and differentiation decisions within specific cell lineages, the cardiac-associated GATA factors function in multiple germ layers, cell types, and patterning processes. Defining the target genes for GATA factors that control patterning and morphogenetic programs provides an important future challenge.
FIG. 6.
Based on the data presented, we hypothesize that the levels or boundaries of GATA-4/5/6 expression delineate the region of the heart field that will express Nkx2 genes and be competent for cardiomyocyte development. When GATA factors are overexpressed, cardiomyocyte differentiation can be repressed. Inhibition of GATA-dependent gene expression results in an expanded pattern of Nkx2.5 transcripts, perhaps providing competence to a larger part of the heart field to contribute to the cardiomyocyte population. The model is consistent with additional reports in the literature demonstrating the ability of enhanced levels of GATA-6 (Gove et al., 1997) or Nkx2.5 (Cleaver et al., 1996) to inhibit or expand, respectively, the population of differentiated cardiomyocytes (although note that this is a relatively late effect and neither GATA-4 or GATA-6 overexpression alone is reported to alter Nkx2.5 transcript patterns). The domain of Nkx2 expression in the pharyngeal endoderm is not indicated in the schematic, although we note that RA does not activate GATA expression in the pharyngeal endoderm and also does inhibit Nkx2.5 transcription in this region.
